Liver Cancer
Latest News
Advertisement
Advertisement
In this segment, David Liu, shares a case study of a 33-year-old woman with stage 4 colorectal cancer that had metastasized to the liver.
An analysis of patients with advanced hepatocellular carcinoma and elevated AFP who received second-line Cyramza showed improved survival, according to data from the phase 3 REACH study.
Researchers need to learn more about the biology of liver cancer to develop better treatments.
Refined treatments and targeted drugs signal slow yet significant progress for liver cancer.
Advertisement
Advertisement
Trending on CURE
1
Most Patients With HER2+ Breast Cancer Miss Standard Treatment, Study Shows
2
FDA Fast Tracks LBL-034 in Relapsed or Refractory Multiple Myeloma
3
Onvansertib Combo Improves Outcomes in First-Line RAS-Mutated mCRC
4
Expert insights into Biomarker-Driven Care and Emerging Targets in GI Cancer
5